AMBALAL SARABHAI ENTERPRISES
Back to Balance Sheet
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹39 Cr | ₹35 Cr | ₹29 Cr | ₹32 Cr | ₹35 Cr |
What is the latest Contingent Liabilities ratio of AMBALAL SARABHAI ENTERPRISES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹39 Cr |
| Mar2025 | ₹35 Cr |
| Mar2024 | ₹29 Cr |
| Mar2023 | ₹32 Cr |
| Mar2022 | ₹35 Cr |
How is Contingent Liabilities of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹39 Cr | 10.69 | |
| Mar2025 | ₹35 Cr | 22.25 | |
| Mar2024 | ₹29 Cr | -11.91 | |
| Mar2023 | ₹32 Cr | -8.19 | |
| Mar2022 | ₹35 Cr | - | |
Compare Contingent Liabilities of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹297.4 Cr | 0.3% | -2.6% | 11.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | -1.4% | -6.5% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,311.0 Cr | -2% | -2.7% | 40.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,079.0 Cr | -1.8% | -7% | 29.6% | Stock Analytics | |
| CIPLA | ₹107,528.0 Cr | 0.1% | -3% | -15.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,667.0 Cr | 0.2% | 6% | -2.4% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | 0.3% |
-2.6% |
11.9% |
| SENSEX | 2.7% |
-0.7% |
-10.5% |
You may also like the below Video Courses